Synergy XVI The Elekta Synergy S is intended to be used for radiation therapy treatment of malignant neoplastic diseases, as determined by a licensed medical practitioner.
Published February 26, 2014 · Recall initiated: November 25, 2013
Summary
FDA records medical device Class II recall Z-1061-2014, published February 26, 2014 and initiated November 25, 2013. Recalling firm: Elekta, Inc.; Status: Terminated; Reported quantity: 312; Lot: Model 4.2.1. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Potential collision risk when using XVI and external beam shaping devices.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Elekta, Inc.
- Distributor
- Worldwide Distribution: US (nationwide) including Puerto Rico and the states of: AL, AK, AZ, CA, CO, CT, FL, GA, IL, IA, KY, MD, MA, MI, MN, MS, MT, NE, NV, NJ, NM, NY, NC, OH, OK, OR, PA, SC, TN, TX, VT, VA, WA, WV, WI, DC, and Internationally to: Algeria, Australia, Austria, Belarus, Belgium, Brazil, Canada, Chile, China, Cyprus, Czech Republic, France, Germany, Greece, Hong Kong, India, Israel, Italy, Japan, Malaysia, Mexico, Pakistan, Portugal, Russia, Singapore, Slovakia, South Korea, Spain, Taiwan, Thailand, and United Kingdom.
- Lot
- Model 4.2.1
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDABrand Name: Geneva Product Name: Brachytherapy Applicator Product Description: The device is intended forJuly 15, 2026
- FDABrand Name: Brachytherapy Applicator Product Name: Advanced Gynecological Applicator Product Description: TheJuly 15, 2026
- FDABrand Name: Fletcher CT/MR Shielded Applicator Set Product Name: Intracavitary Remote Afterloading ApplicatorJuly 15, 2026
- FDAMOSAIQ Oncology Information SystemJune 17, 2026
- FDASynergy XVI XVI can incorrectly calculate the target position of the treatment table, because of an error thatFebruary 26, 2014
- FDABausch & Lomb AKREOS AO Micro Incision Lens The Akreos IOL intended for primary implantation in the capsularFebruary 26, 2014
Questions about this recall
Was Synergy XVI The Elekta Synergy S is intended to be used for radiation therapy treatment of malignant neoplastic diseases, as determined by a licensed medical practitioner. recalled?
Yes. FDA published recall Z-1061-2014 on February 26, 2014. Reported hazard: Potential collision risk when using XVI and external beam shaping devices.
What should I do if I have this product?
Voluntary: Firm initiated · Letter